glp-1 heart failure medications are not just for weight loss — they are the most important drug class of our lifetime. 🫀 A 2025 meta-analysis of 99,599 patients confirmed: ✓ 20% reduction in major The Cardiovascular Biology of Glucagon-like

Mechanisms behind rTPA-induced HT include thrombolytic and non-thrombolytic actions

Because it can improve insulin sensitivity and hormone balance, it may offer some advantages to those following a weight loss plan

Kerksick, C., & Willoughby, D

It helps improve blood sugar, metabolism, and cardiovascular health, and it has anti-inflammatory properties that can affect biomarkers

The study, which ended prematurely due to a higher mortality rate in the intensive treatment group, failed to report significant reduction in major cardiovascular events, giving a notion that intensive therapy was associated with significant harm in high risk patients [6]